Explore 3 Stock Ideas & Industry Insights Download Free Report

Turn Therapeutics Inc. Common Stock

Company price
8.64 USD -0.25 ( 2.81%)
Last update at 2026-11-19T21:00:00Z
VOLUME
124866
Market Cap
408.75M

Momentum Score

…

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
8.57
Low
9.20
High
52 Week Price Range
2.57
Low
14.39
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High

Key Metrics*

Previous Close
8.89
Dividend Yield
-
Revenue TTM
0.00M
Revenue Per Share
-
Gross Profit TTM
-1.61M
Debt / Equity
0.02
ROE
-686.28%
Net Debt
-5.00M
ROCE
-51.86%
Diluted EPS TTM
-0.28

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Income before tax -3.19M -1.77M -2.29M
Net income -3.19M -1.77M -2.29M
Selling general administrative 5.59M 1.55M 2.30M
Reconciled depreciation 0.05M 0.05M 0.04M
Ebit -3.19M -1.77M -2.29M
Ebitda -3.14M -1.72M -2.25M
Depreciation and amortization 0.05M 0.05M 0.04M
Operating income -5.86M -1.80M -2.31M
Other operating expenses 5.86M 1.80M 2.31M
Interest income 0.03M 0.03M 0.02M
Net interest income -0.47M 0.03M 0.02M
Total revenue 0.00M 0.00M 0.00M
Total operating expenses 5.86M 1.80M 2.31M
Total other income expense net 2.66M 0.03M 0.02M
Net income from continuing ops -3.19M -1.77M -2.29M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Total assets 12.16M 2.05M 2.01M
Intangible assets 0.92M 0.82M 0.77M
Other current assets 0.12M 0.23M 0.02M
Total liab 7.48M 2.23M 1.93M
Total stockholder equity 4.69M -0.18M 0.09M
Other current liab 3.03M 0.67M 0.46M
Common stock 0.00M 0.00M 0.00M
Capital stock 0.00M 0.00M 0.00M
Retained earnings -22.39M -19.20M -17.43M
Cash 5.08M 0.87M 1.18M
Total current liabilities 6.00M 0.71M 0.49M
Net debt -5.00M -0.75M -1.16M
Short term debt 0.05M 0.04M 0.03M
Short long term debt total 0.08M 0.12M 0.03M
Other stockholder equity 27.07M 19.02M 17.51M
Total current assets 5.20M 1.10M 1.20M
Accounts payable 2.93M - -
Non currrent assets other 6.04M 0.01M 0.01M
Non current assets total 6.97M 0.95M 0.81M
Capital lease obligations 0.08M 0.12M 0.03M
Breakdown 2025-12-31 2024-12-31 2023-12-31
Type yearly yearly yearly
Date 2025-12-31 2024-12-31 2023-12-31
Investments - -0.10M -0.04M
Total cashflows from investing activities -0.15M -0.10M -0.04M
Total cash from financing activities 6.92M 1.15M 0.50M
Net income -3.19M -1.77M -2.29M
Change in cash 4.20M -0.31M -0.92M
Begin period cash flow 0.87M 1.18M 2.10M
End period cash flow 5.08M 0.87M 1.18M
Total cash from operating activities -2.56M -1.36M -1.38M
Issuance of capital stock 6.92M 1.15M 0.50M
Depreciation 0.05M 0.05M 0.04M
Other cashflows from investing activities -0.15M - -
Capital expenditures 0.15M 0.10M 0.04M
Change in working capital 2.37M -0.00M 0.23M
Stock based compensation 0.42M 0.35M 0.64M
Other non cash items -2.21M 0.01M 0.00M
Free cash flow -2.72M -1.46M -1.42M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(USD)
Price
(USD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
TTRX
Turn Therapeutics Inc. Common Stock
-0.25
2.81%
8.64 - - - 596.40
NVO
Novo Nordisk A/S
-0.54
1.36%
38.90 41.58 31.15 2.13 32.99
VRTX
Vertex Pharmaceuticals Inc
-
-%
520.66 30.22 24.27 10.36 6.50
REGN
Regeneron Pharmaceuticals Inc
2.34
0.25%
923.34 29.07 20.12 7.57 3.82
ARGNF
argenx SE
-
-%
965.00 45.77 31.25 13.84 7.12

Profile*

Turn Therapeutics Inc. Common Stock

Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California.

250 N Westlake Blvd, Westlake Village, CA, United States, 91362

818 546 4011

2

Name Title Year Born
Mr. Bradley E. Burnam Founder, CEO & Director 1980
Mr. Zuraiz Chaudhary Interim CFO, VP of Finance & Chief Accounting Officer 1996
Dr. Neilesh Shailesh Ghodadra M.D. Chief Medical Officer & Director 1981
Mohammed Zubair Controller NA
Dr. Stephen M. Hahn FASTRO, M.D. Executive Clinical & Regulatory Lead 1960

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…